Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (193) 193
humans (190) 190
life sciences & biomedicine (181) 181
male (170) 170
middle aged (122) 122
aged (117) 117
medical sciences (109) 109
biological and medical sciences (108) 108
prostate cancer (108) 108
oncology (103) 103
tumors (78) 78
nephrology. urinary tract diseases (76) 76
tumors of the urinary system (74) 74
urinary tract. prostate gland (72) 72
cancer (62) 62
risk factors (62) 62
prostatic neoplasms - pathology (61) 61
prostatic neoplasms - prevention & control (57) 57
abridged index medicus (54) 54
research (48) 48
urology & nephrology (47) 47
clinical trials (44) 44
prostate (41) 41
female (39) 39
prevention (39) 39
gynecology. andrology. obstetrics (37) 37
male genital diseases (37) 37
prostate-specific antigen - blood (36) 36
aged, 80 and over (34) 34
care and treatment (34) 34
case-control studies (33) 33
adult (31) 31
prostatic neoplasms - blood (31) 31
treatment outcome (29) 29
health aspects (28) 28
prognosis (28) 28
risk (28) 28
urology (28) 28
follow-up studies (27) 27
prostatic neoplasms - mortality (27) 27
biopsy (25) 25
finasteride - therapeutic use (25) 25
prostatic neoplasms (25) 25
prostatic neoplasms - epidemiology (25) 25
medicin och hälsovetenskap (23) 23
prostate-specific antigen (23) 23
randomized controlled trials as topic (23) 23
risk assessment (23) 23
finasteride (22) 22
general & internal medicine (22) 22
medicine, general & internal (22) 22
prostatic neoplasms - drug therapy (22) 22
survival rate (22) 22
proportional hazards models (20) 20
prospective studies (20) 20
pharmacology. drug treatments (19) 19
polymorphism, single nucleotide (19) 19
public, environmental & occupational health (19) 19
survival analysis (19) 19
epidemiology (18) 18
neoplasm staging (18) 18
prostatectomy (18) 18
prostatic neoplasms - genetics (18) 18
antineoplastic combined chemotherapy protocols - therapeutic use (17) 17
diagnosis (17) 17
prostatic neoplasms - diagnosis (17) 17
antineoplastic agents (16) 16
double-blind method (16) 16
neoplasm grading (16) 16
odds ratio (16) 16
oncology, experimental (16) 16
analysis (15) 15
chemotherapy (15) 15
disease prevention (15) 15
logistic models (15) 15
neoplasm metastasis (15) 15
prostatic neoplasms - surgery (15) 15
time factors (15) 15
biomarkers, tumor - blood (14) 14
multivariate analysis (14) 14
confidence intervals (13) 13
genetic predisposition to disease (13) 13
medical and health sciences (13) 13
men (13) 13
metastasis (13) 13
prostatic neoplasms - etiology (13) 13
research design (13) 13
selenium (13) 13
disease-free survival (12) 12
health risks (12) 12
predictive value of tests (12) 12
united states (12) 12
usage (12) 12
vitamin e (12) 12
5-alpha reductase inhibitors - therapeutic use (11) 11
antineoplastic agents - therapeutic use (11) 11
cancer and oncology (11) 11
cancer och onkologi (11) 11
clinical trials, phase iii as topic (11) 11
cohort studies (11) 11
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Vitamin E and the risk of prostate cancer: The selenium and vitamin E cancer prevention trial (SELECT)
by Klein, Eric A and Thompson Jr, Ian M and Tangen, Catherine M and Crowley, John J and Lucia, Scott and Goodman, Phyllis J and Minasian, Lori M and Ford, Leslie G and Parnes, Howard L and Gaziano, J. Michael and Karp, Daniel D and Lieber, Michael M and Walther, Philip J and Klotz, Laurence and Parsons, J. Kellogg and Chin, Joseph L and Darke, Amy K and Lippman, Scott M and Goodman, Gary E and Meyskens Jr, Frank L and Baker, Laurence H
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 10/2011, Volume 306, Issue 14, pp. 1549 - 1556
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Follow-Up Studies | Humans | Middle Aged | Male | Risk | Vitamin E - adverse effects | Incidence | Prostatic Neoplasms - epidemiology | Antioxidants - administration & dosage | Vitamin E - administration & dosage | Antioxidants - adverse effects | Aged | Dietary Supplements - adverse effects | Prostatic Neoplasms - prevention & control | Selenium - administration & dosage | Mens health | Vitamin E | Clinical trials | Selenium | Comparative analysis | Prostate cancer | Risk factors | Diets | Intervention | Prevention | prostate cancer | Age | Vitamins | Cancer
Journal Article
Details down arrow
2. Full Text Docetaxel and atrasentan versus docetaxel and placebo for men with advanced castration-resistant prostate cancer (SWOG S0421): a randomised phase 3 trial
by Quinn, David I, Dr and Tangen, Catherine M, DrPH and Hussain, Maha, Prof and Lara, Primo N, Prof and Goldkorn, Amir, MD and Moinpour, Carol M, PhD and Garzotto, Mark G, MD and Mack, Philip C, PhD and Carducci, Michael A, Prof and Monk, J Paul, MD and Twardowski, Przemyslaw W and Van Veldhuizen, Peter J, MD and Agarwal, Neeraj, MD and Higano, Celestia S, Prof and Vogelzang, Nicholas J, MD and Thompson, Ian M, Prof
The lancet oncology, ISSN 1470-2045, 2013, Volume 14, Issue 9, pp. 893 - 900
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Bone Neoplasms - mortality | Neoplasms, Hormone-Dependent - mortality | Prostatic Neoplasms - pathology | Prognosis | Double-Blind Method | Follow-Up Studies | Humans | Middle Aged | Bone Neoplasms - secondary | Pyrrolidines - administration & dosage | Male | Survival Rate | Prostatic Neoplasms - mortality | Taxoids - administration & dosage | Neoplasm Grading | Castration | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoplasms, Hormone-Dependent - pathology | Adult | Aged | Bone Neoplasms - drug therapy | Neoplasms, Hormone-Dependent - drug therapy | Prostatic Neoplasms - drug therapy | Product development | Hospitals, Veterans | Prostate cancer | Docetaxel | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Long-Term Survival of Participants in the Prostate Cancer Prevention Trial
by Thompson, Ian M and Goodman, Phyllis J and Tangen, Catherine M and Parnes, Howard L and Minasian, Lori M and Godley, Paul A and Lucia, M. Scott and Ford, Leslie G
The New England journal of medicine, ISSN 0028-4793, 08/2013, Volume 369, Issue 7, pp. 603 - 610
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Tumors of the urinary system | Urinary tract. Prostate gland | Gynecology. Andrology. Obstetrics | General aspects | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Male genital diseases | Tumors | Prostatic Neoplasms - pathology | Follow-Up Studies | Humans | Kaplan-Meier Estimate | Male | Risk | Survival Rate | 5-alpha Reductase Inhibitors - therapeutic use | Prostatic Neoplasms - mortality | Incidence | Prostatic Neoplasms - epidemiology | Neoplasm Grading | Finasteride - therapeutic use | Prostatic Neoplasms - prevention & control | Prevention | Finasteride | Patient outcomes | Clinical trials | Dosage and administration | Research | Prostate cancer | Disease prevention | Mens health | Biopsy | Men | Survival | Cancer therapies | Prostate | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Effect of intravesical instillation of gemcitabine vs saline immediately following resection of suspected low-grade non-muscle-invasive bladder cancer on tumor recurrence SWOG S0337 randomized clinical trial
by Messing, Edward M and Tangen, Catherine M and Lerner, Seth P and Sahasrabudhe, Deepak M and Koppie, Theresa M and Wood, David P and Mack, Philip C and Svatek, Robert S and Evans, Christopher P and Hafez, Khaled S and Culkin, Daniel J and Brand, Timothy C and Karsh, Lawrence I and Holzbeierlein, Jeffrey M and Wilson, Shandra S and Wu, Guan and Plets, Melissa and Vogelzang, Nicholas J and Thompson, Ian M
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 05/2018, Volume 319, Issue 18, pp. 1880 - 1888
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Double-Blind Method | Follow-Up Studies | Neoplasm Recurrence, Local - prevention & control | Neoplasm Invasiveness | Deoxycytidine - administration & dosage | Humans | Middle Aged | Carcinoma, Papillary - drug therapy | Male | Sodium Chloride - administration & dosage | Urinary Bladder Neoplasms - drug therapy | Carcinoma, Papillary - pathology | Antimetabolites, Antineoplastic - administration & dosage | Incidence | Antimetabolites, Antineoplastic - adverse effects | Urinary Bladder Neoplasms - pathology | Deoxycytidine - adverse effects | Female | Aged | Neoplasm Recurrence, Local - epidemiology | Administration, Intravesical | Deoxycytidine - analogs & derivatives | Urothelium | Urothelial cancer | Gemcitabine | Toxicity | Invasiveness | Cytology | Clinical trials | Bladder | Muscles | Bladder cancer | Patients | Cancer surgery | Rank tests | Mens health | Motivation | Tumors | Cancer
Journal Article
Details down arrow
5. Full Text The Influence of Finasteride on the Development of Prostate Cancer
by Thompson, Ian M and Goodman, Phyllis J and Tangen, Catherine M and Lucia, M. Scott and Miller, Gary J and Ford, Leslie G and Lieber, Michael M and Cespedes, R. Duane and Atkins, James N and Lippman, Scott M and Carlin, Susie M and Ryan, Anne and Szczepanek, Connie M and Crowley, John J and Coltman, Charles A
The New England journal of medicine, ISSN 0028-4793, 07/2003, Volume 349, Issue 3, pp. 215 - 224
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | Chemotherapy | Medical sciences | Antineoplastic agents | Pharmacology. Drug treatments | Prostatic Neoplasms - pathology | Humans | Middle Aged | 5-alpha Reductase Inhibitors | Male | Morbidity | Prostate-Specific Antigen - blood | Prostatic Neoplasms - epidemiology | Antineoplastic Agents, Hormonal - adverse effects | Prostate - pathology | Finasteride - adverse effects | Biopsy | Antineoplastic Agents, Hormonal - therapeutic use | Aged | Finasteride - therapeutic use | Prostatic Neoplasms - prevention & control | Prostatic Neoplasms - chemically induced | Neoplasms, Hormone-Dependent - prevention & control | Prevention | Evaluation | Development and progression | Finasteride | Prostate cancer | Men | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter
by Thompson, Ian M and Pauler, Donna K and Goodman, Phyllis J and Tangen, Catherine M and Lucia, M. Scott and Parnes, Howard L and Minasian, Lori M and Ford, Leslie G and Lippman, Scott M and Crawford, E. David and Crowley, John J and Coltman, Charles A
The New England journal of medicine, ISSN 0028-4793, 05/2004, Volume 350, Issue 22, pp. 2239 - 2246
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Tumors of the urinary system | Urinary tract. Prostate gland | Gynecology. Andrology. Obstetrics | General aspects | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Male genital diseases | Tumors | Prostatic Neoplasms - pathology | Prevalence | Humans | Middle Aged | Male | Risk | Prostate-Specific Antigen - blood | Prostatic Neoplasms - epidemiology | Prostate - pathology | Biopsy | Antineoplastic Agents, Hormonal - therapeutic use | Aged, 80 and over | Prostatic Neoplasms - blood | Aged | Finasteride - therapeutic use | Prostatic Neoplasms - prevention & control | Clinical trials | Medical diagnosis | Prostate cancer | Men | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Intermittent versus Continuous Androgen Deprivation in Prostate Cancer
by Hussain, Maha and Tangen, Catherine M and Berry, Donna L and Higano, Celestia S and Crawford, E. David and Liu, Glenn and Wilding, George and Prescott, Stephen and Kanaga Sundaram, Subramanian and Small, Eric Jay and Dawson, Nancy Ann and Donnelly, Bryan J and Venner, Peter M and Vaishampayan, Ulka N and Schellhammer, Paul F and Quinn, David I and Raghavan, Derek and Ely, Benjamin and Moinpour, Carol M and Vogelzang, Nicholas J and Thompson, Ian M
The New England journal of medicine, ISSN 0028-4793, 04/2013, Volume 368, Issue 14, pp. 1314 - 1325
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Tumors of the urinary system | Urinary tract. Prostate gland | Gynecology. Andrology. Obstetrics | General aspects | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Male genital diseases | Tumors | Confidence Intervals | Follow-Up Studies | Anilides - adverse effects | Humans | Middle Aged | Male | Gonadotropin-Releasing Hormone - analogs & derivatives | Nitriles - administration & dosage | Antineoplastic Agents, Hormonal - adverse effects | Neoplasm Metastasis - drug therapy | Penile Erection - drug effects | Gonadotropin-Releasing Hormone - therapeutic use | Goserelin - adverse effects | Prostatic Neoplasms - drug therapy | Goserelin - administration & dosage | Prostatic Neoplasms - pathology | Tosyl Compounds - administration & dosage | Drug Administration Schedule | Antineoplastic Agents, Hormonal - administration & dosage | Prostate-Specific Antigen - blood | Prostatic Neoplasms - mortality | Tosyl Compounds - adverse effects | Anilides - administration & dosage | Survival Analysis | Quality of Life | Aged | Androgen Antagonists - administration & dosage | Nitriles - adverse effects | Usage | Care and treatment | Patient outcomes | Androgen suppression therapy | Drug therapy | Prostate cancer | Methods | Cancer | Statistical analysis | Mental disorders | Prostate-specific antigen | Clinical trials | Patients | Survival | Quality of life | Metastases | Androgens | Castration | Stem cells | Luteinizing hormone | Prostate | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Adjuvant radiotherapy for pathologically advanced prostate cancer: A randomized clinical trial
by Thompson Jr, Ian M and Tangen, Catherine M and Paradelo, Jorge and Lucia, M. Scott and Miller, Gary and Troyer, Dean and Messing, Edward and Forman, Jeffrey and Chin, Joseph and Swanson, Gregory and Canby-Hagino, Edith and Crawford, E. David
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 11/2006, Volume 296, Issue 19, pp. 2329 - 2335
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Radiotherapy Dosage | Prostatic Neoplasms - radiotherapy | Follow-Up Studies | Prostatic Neoplasms - surgery | Neoplasm Invasiveness | Humans | Middle Aged | Male | Prostate-Specific Antigen - blood | Prostatic Neoplasms - mortality | Cross-Over Studies | Neoplasm Metastasis | Survival Analysis | Prostatic Neoplasms - blood | Adult | Prostatectomy | Aged | Radiotherapy, Adjuvant | Survival analysis | Surgery | Clinical trials | Radiation therapy | Prostate cancer | Clinical outcomes | Tumors
Journal Article
Details down arrow
9. Erectile dysfunction and subsequent cardiovascular disease
by Thompson, Ian M and Tangen, Catherine M and Goodman, Phyllis J and Probstfield, Jeffrey L and Moinpour, Carol M and Coltman, Charles A
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 12/2005, Volume 294, Issue 23, pp. 2996 - 3002
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Humans | Middle Aged | Risk Factors | Proportional Hazards Models | Cardiovascular Diseases - epidemiology | Male | Aged | Erectile Dysfunction - epidemiology | Cohort Studies | Cardiovascular disease | Reproductive system | Sexual disorders | Risk factors
Journal Article
Details down arrow
10. Full Text Long-Term Effects of Finasteride on Prostate Cancer Mortality
by Goodman, Phyllis J and Darke, Amy K and Tangen, Catherine M and Lucia, M. Scott and Ford, Leslie G and Minasian, Lori M and Parnes, Howard L and LeBlanc, Michael L and Thompson, Ian M
The New England journal of medicine, ISSN 0028-4793, 01/2019, Volume 380, Issue 4, pp. 393 - 394
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Early Detection of Cancer | Humans | Middle Aged | Male | 5-alpha Reductase Inhibitors - therapeutic use | Prostate-Specific Antigen - blood | Prostatic Neoplasms - mortality | Finasteride - adverse effects | Neoplasm Grading | 5-alpha Reductase Inhibitors - adverse effects | Finasteride - therapeutic use | Prostatic Neoplasms - prevention & control | Prostatic Neoplasms - chemically induced | Disease prevention | Prostate | Prostate cancer | Men | Tumors | Long-term effects | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Prostate Cancer — Uncertainty and a Way Forward
by Thompson, Ian M and Tangen, Catherine M
The New England journal of medicine, ISSN 0028-4793, 07/2012, Volume 367, Issue 3, pp. 270 - 271
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Male | Prostatectomy | Watchful Waiting | Prostatic Neoplasms - surgery | Humans | Prostatic Neoplasms - mortality | Treatment outcome | Evaluation | Care and treatment | Usage | Diagnosis | Prostate cancer | Confidence intervals | Wilt | Prostate-specific antigen | Mortality | Men | Prostate | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights